Core Scientific (CORZZ) Asset Writedowns and Impairment (2022 - 2026)

Core Scientific's Asset Writedowns and Impairment history runs 4 years deep, the most recent figure standing at $266.5 million for Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment changed N/A year-over-year to $266.5 million; the TTM figure through Mar 2026 stood at $277.8 million (changed N/A YoY), while the FY2025 annual figure was $11.4 million, changed N/A from the prior year.
• Asset Writedowns and Impairment came in at $266.5 million for Q1 2026 at Core Scientific, up from $11.4 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $790.8 million in Q2 2022 to a low of -$784.8 million in Q3 2022.
• A 4-year average of $41.0 million and a median of $11.4 million in 2025 frame the typical range for Asset Writedowns and Impairment.
• On a YoY basis, Asset Writedowns and Impairment climbed as much as 111.68% in 2025 and fell as far as 111.68% in 2025.
• Core Scientific's Asset Writedowns and Impairment stood at $3.1 million in 2022, then tumbled by 3277.43% to -$97.3 million in 2024, then surged by 111.68% to $11.4 million in 2025, then jumped by 2246.05% to $266.5 million in 2026.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $266.5 million, $11.4 million, and -$97.3 million for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison